Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure (1974)

Content Provider	CiteSeerX
Author	Franciosa, A. Mikulic, Esteban Cohn, Jay N. Jose, Ernesto Fabie, Anastacia
Abstract	The efficacy of orally administered isosorbide dinitrate (IS) has been questioned. Recently vasodilators have been shown to lower left ventricular filling pressure (LVFP) and raise cardiac output in heart failure. In the present study oral IS was evaluated in 12 patients with high LVFP due to heart failure. After right heart catheterization, patients with LVFP> 14 mm Hg were randomized double-blind to receive either 20 mg IS or placebo (P). Supine heart rate (HR), arterial pressure (BP), and LVFP were monitored for five hours. After this the alternate drug (P or IS) was given, followed by five more hours of monitoring. In the 12 patients after receiving IS, LVFP reached a peak reduction of 6.7 mm Hg (-26%, P < 0.005) at 30 min. Significant reduction persisted for 4.5 hours. Blood pressure fell concomitantly with the LVFP. At 60 min HR was unchanged, systolic BP was reduced by 8.9 mm Hg (P < 0.025) and diastolic BP by 6.3 mm Hg (P < 0.005). In the ten patients receiving P, control values were not significantly different from those given IS, and after receiving P, HR, BP, and LVFP failed to change significantly over the next five hours. Thus, oral IS produces a sustained reduction in LVFP and therefore merits further evaluation as chronic therapy for left ventricular failure. Additional Indexing Words: Long-acting nitrates Vasodilators
File Format	PDF
Journal	Circulation
Language	English
Publisher Date	1974-01-01
Access Restriction	Open
Content Type	Text
Resource Type	Article